about
Antigen-based immunotherapy for autoimmune disease: current statusIntracellular nucleic acid sensors and autoimmunityHomeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus.Epitope mapping of the U1 small nuclear ribonucleoprotein particle in patients with systemic lupus erythematosus and mixed connective tissue disease.Diagnostic value and clinical laboratory associations of antibodies against recombinant ribosomal P0, P1 and P2 proteins and their native heterocomplex in a Caucasian cohort with systemic lupus erythematosus.Co-Positivity for Anti-dsDNA, -Nucleosome and -Histone Antibodies in Lupus Nephritis Is Indicative of High Serum Levels and Severe Nephropathy.Dissecting the relationships of IgG subclasses and complements in membranous lupus nephritis and idiopathic membranous nephropathy.Autoantibody determination in the diagnosis of systemic lupus erythematosus.CD4+Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice.The genetics and biology of Irf5-mediated signaling in lupus.Hematopoietic stem cell transplantation for systemic lupus erythematosus, the antiphospholipid syndrome and bullous skin diseases.Harnessing regulatory T cells for the therapy of lupus and other autoimmune diseases.Viruses as potential pathogenic agents in systemic lupus erythematosus.The spectrum of anti-chromatin/nucleosome autoantibodies: independent and interdependent biomarkers of disease.Differential immunoglobulin class-mediated responses to components of the U1 small nuclear ribonucleoprotein particle in systemic lupus erythematosus and mixed connective tissue diseasePostinfectious immunodeficiency and autoimmunity: pathogenic and clinical values and implications.Simultaneous positivity for anti-DNA, anti-nucleosome and anti-histone antibodies is a marker for more severe lupus nephritis.A serological switching from anti-dsDNA to anti-Sm antibodies coincided with severe clinical manifestations of systemic lupus erythematosus (hemophagocytosis, profundus and psychosis).Galectin-1-induced down-regulation of T lymphocyte activation protects (NZB x NZW) F1 mice from lupus-like disease.Subset size, activation threshold and distribution of autoreactive MZ and FO B cells do not differ in a sex-specific manner in the NZB/W F1 murine lupus model: an experimental mouse study.Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?Variables associated to fetal microchimerism in systemic lupus erythematosus patients.Catalytic antibodies in patients with systemic lupus erythematosus
P2860
Q26852915-4671EED1-7532-4335-9280-6FEB2A24D724Q26997316-84043491-98B5-4F92-9470-BB3170E7CB06Q33591655-8F304C57-64CB-41B8-9F37-A824309DB21CQ33631871-7EA26D42-D61C-464E-AF3C-5A0BE1BCB70CQ35620320-B9E9DB02-F24E-4C13-A878-2F8954E769C0Q35806070-0E3381F7-0296-4565-9088-1B6EC64CDA79Q36320187-9A020444-861F-4037-A8E8-E9AFC2C571F0Q36570675-00646518-67C7-4130-AA8A-A8A3CA042572Q36903043-C2C4DD27-89D8-4190-92FE-D23CC7C8D17DQ37030639-0B9087C0-9863-4DE4-9C7E-C5EB8DE0271AQ37311073-04A8C3AA-3590-4D14-BBFF-C721BDC71B6AQ37773268-633D7A87-14F0-45A1-96F7-033E649925A7Q38206951-FBDA77EB-2C38-4C51-BC6E-997DCC60BF6BQ38209945-7A243630-061A-4E61-A28D-12C065347AADQ41773764-6BF54A56-D3C2-4B5E-8D96-C30ED44FBA18Q43944431-91E1FEC4-D926-4FE3-B630-5636AC62A61BQ44439756-028F16C6-9334-44F4-AC17-008B01A9DF35Q44916274-E17F0952-82E9-4691-AFAF-1D23E3B15776Q46378496-52B5072A-0F02-4B8A-9D77-2B5C46C84CA0Q47360761-034C1A6C-6BDA-404C-B743-0CFBE6E167BDQ52597638-FF6918BC-BC26-4E8C-AF60-047515DD97E2Q52900293-6EF1D7E1-529B-452A-8DAC-6A9E54951547Q58796857-DB63DB26-82ED-459E-B53F-7DCE726D3965
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Key autoantigens in SLE.
@ast
Key autoantigens in SLE.
@en
type
label
Key autoantigens in SLE.
@ast
Key autoantigens in SLE.
@en
prefLabel
Key autoantigens in SLE.
@ast
Key autoantigens in SLE.
@en
P356
P1433
P1476
Key autoantigens in SLE.
@en
P2093
Riemekasten G
P304
P356
10.1093/RHEUMATOLOGY/KEH688
P577
2005-05-18T00:00:00Z